GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

Rating:
Buy AEGR
up 24.80 %

Aegerion Pharmaceuticals, Inc. (AEGR) rated Buy with price target $110 by Canaccord Genuity

Posted on: Wednesday,  Jul 31, 2013  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on 07/31/2013. Previously Canaccord Genuity rated Buy Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on
03/26/2012., when the stock price was $14.23. Since then, Aegerion Pharmaceuticals, Inc. has gained 24.81% as of 01/27/2016's recent price of $17.76.
If you would have followed the previous Canaccord Genuity's recommendation on AEGR, you would have gained 24.8% of your investment in 1402 days.

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/31/2013 9:25 AM Buy
None
84.25 110.00
as of 12/13/2013
1 Week down  -1.19 %
1 Month down  -19.47 %
3 Months down  -27.29 %
1 YTD up  160.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2013 9:25 AM Buy
None
66.00 90.00
3/26/2012 9:25 AM Buy
None
14.23 27.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy